| For: | Li XY, Ji PX, Ni XX, Chen YX, Sheng L, Lian M, Guo CJ, Hua J. Regulation of PPAR-γ activity in lipid-laden hepatocytes affects macrophage polarization and inflammation in nonalcoholic fatty liver disease. World J Hepatol 2022; 14(7): 1365-1381 [PMID: 36158922 DOI: 10.4254/wjh.v14.i7.1365] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i7/1365.htm |
| Number | Citing Articles |
| 1 |
Jie Liu, Mengran Wang, Yong Zhao. The Regulatory Network of Transcription Factors in Macrophage Polarization. ImmunoTargets and Therapy 2025; doi: 10.2147/ITT.S494550
|
| 2 |
Bai-Yu Xie, Lan Cai, Xiao-Qin Zhu, Ming-Gang Li, Jiang-Yuan Zhao, Zhang-Gui Ding. Technological innovation: Aspergillus niger single-strain-fermented Pu-erh tea significantly regulates lipid metabolism and obesity in C57BL/6J mice. Food Bioscience 2026; 84 doi: 10.1016/j.fbio.2026.109811
|
| 3 |
Olenka Puelles Samaniego, Óscar Gustavo Huamán Gutiérrez, Paula Sofía Turriate Aguilar. Efecto del pulverizado de Chenopodium ambrosioides (paico) sobre los marcadores del metabolismo lipídico en hígado de ratas, frente al consumo de etanol y fructosa.. Nutrición Clínica y Dietética Hospitalaria 2024; 44(4) doi: 10.12873/444puelles
|
| 4 |
Alexis Brantly, Kyle Yeakle, Michael J Bouchard, Peter J Gaskill, Michael R Nonnemacher. The role of liver macrophages in viral liver pathogenesis. Journal of Leukocyte Biology 2025; 117(9) doi: 10.1093/jleuko/qiaf088
|
| 5 |
Ajit Singh Brar, Tejasvini Khanna, Aalam Sohal, Juniali Hatwal, Vishal Sharma, Carol Singh, Akash Batta, Praveen Chandra, Bishav Mohan. Metabolic dysfunction-associated steatotic liver disease and heart failure with preserved ejection fraction: A state-of-the-art review. World Journal of Cardiology 2026; 18(1): 111954 doi: 10.4330/wjc.v18.i1.111954
|
| 6 |
Fan-E Cheng, Shihao Zheng, Wenying Qi, Xinyu Zhao, Chunfeng Mei, Qiuyue Wang, Yaxi Zhang, Xiaobin Zao, Qiyao Liu, Hongbo Du, Yong'an Ye. Mechanisms of macrophage polarization in MASLD and recent advances in targeted therapeutic strategies. Materials Today Advances 2026; 32 doi: 10.1016/j.mtadv.2026.101016
|
| 7 |
Giovanni Musso, Francesca Saba, Maurizio Cassader, Roberto Gambino. Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances. Progress in Lipid Research 2023; 91 doi: 10.1016/j.plipres.2023.101238
|
| 8 |
Xiaoyan Qin, Zhengli Tan, Qi Li, Shiyi Zhang, Dingheng Hu, Denghui Wang, Liangxu Wang, Baoyong Zhou, Rui Liao, Zhongjun Wu, Yanyao Liu. Rosiglitazone attenuates Acute Kidney Injury from hepatic ischemia–reperfusion in mice by inhibiting arachidonic acid metabolism through the PPAR-γ/NF-κB pathway. Inflammation Research 2024; 73(10) doi: 10.1007/s00011-024-01929-x
|
| 9 |
Zhi-Chao Liu, Huan-Jie Fu, Ning-Cen Li, Fang-Jun Deng, Yong-Kang Gan, Yu-Jia Ye, Bing-Hui Huang, Chang Liu, Jin-Hong Chen, Xiao-Feng Li. Systematic pharmacology and experimental validation to elucidate the inflammation-associated mechanism of Huanglian Wendan (HLWD) decoction in the treatment of MAFLD associated with atherosclerosis. Journal of Ethnopharmacology 2025; 337 doi: 10.1016/j.jep.2024.118841
|
| 10 |
Sara E.L. Tolouei, Rodrigo Marcon, Fabiana Cardoso Vilela, Cristina Setim Freitas, Melina Heller, Edineia Lemos de Andrade, Sergio José Macedo Júnior, Adara Áurea dos Santos, Ruth Fernandes Rocha, Guilherme Pasetto Fadanni, Naiani Ferreira Marques, Jarbas Mota Siqueira Júnior, João B. Calixto. Preclinical development of a standardized extract of Ilex paraguariensis A.St.-Hil for the treatment of obesity and metabolic syndrome. Pharmacological Research 2025; 213 doi: 10.1016/j.phrs.2025.107607
|
| 11 |
Saba Kousar, Tumer Arshad, Muhammad Waseem. Nutrient-driven immunometabolism in metabolic disease. Exploration of Endocrine and Metabolic Diseases 2026; 3 doi: 10.37349/eemd.2026.101472
|
| 12 |
Xiangqiong Li, Kunnu Jin, Jindong Fang, Xuan Ma, Jiamei He, Ancheng Lu, Zhuangzhuang Jia, Anhua Shi. Immune crosstalk in metabolic dysfunction-associated steatotic liver disease: interactions between innate and adaptive immunity. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1835197
|
| 13 |
Sabi Ur Rehman, Fazal Ur Rehman, Shafi Ullah Khan, Amir Zeb, Saleha Ashfaq, Shakir Ullah Khan, Waheed Ullah Hafiz, Anjali Chauhan. Phytochemicals at the PPAR–NF‐κB Interface: A Structured Narrative Review of Receptor Pharmacology, Inflammatory Signaling, and Translational Barriers. PPAR Research 2026; 2026(1) doi: 10.1155/ppar/9577380
|
| 14 |
Jingyi Peng, Ankangxin Yan, Guanglei Chen, Xiaojiao Gao, Qi Yu, Weiyi Tian, Kun Cai. The role of lysine acylation in metabolic dysregulation and inflammatory responses within the hepatic immune microenvironment of MASLD. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1933792
|
| 15 |
Qi Shao, Chuxin Zhang, Jie Mu, Jing Ji, Changxiang Li, Chongyang Ma, Fafeng Cheng. Chronic stress-secreted glucocorticoids induce NAFLD-like changes in male rats: oxidative stress/NLRP3 inflammasome signalling. Journal of Molecular Endocrinology 2025; 75(2) doi: 10.1530/JME-25-0056
|
| 16 |
Yanxia Zhang. TCM‐Guided Targeted Therapies Against NLRP3 Inflammasome in NAFLD. Immunity, Inflammation and Disease 2026; 14(6) doi: 10.1002/iid3.70474
|
| 17 |
Jeysson E. Mejía-Guzmán, Ramón A. Belmont-Hernández, Norberto C. Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Metabolic-Dysfunction-Associated Steatotic Liver Disease: Molecular Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies. International Journal of Molecular Sciences 2025; 26(7) doi: 10.3390/ijms26072959
|
| 18 |
Tao Liu, Meihong Yu, Liu Han, Jing Wu, Deliang Liu, Yuyong Tan. The Role of FGF1 in Chronic Liver Diseases. Biomedicines 2026; 14(7) doi: 10.3390/biomedicines14071436
|
| 19 |
Yingxin Tian, Yiming Ni, Ting Zhang, Yemin Cao, Mingmei Zhou, Cheng Zhao. Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1444198
|
| 20 |
Xiao-Wen Wang, Wen-Jie Zheng, Hao-Qi Chen, Tao Huang, Yuan Zhang, Xi-Jing Yan, Wen-Chao Li, Long Zou, Jie-Zhong Wu, Wen-Feng Zhu, Qi-Wei Yang, Gen-Shu Wang, Kun-Peng Hu. Arrb2 in hepatocytes promotes M2 macrophage polarization, ameliorates hepatic ischemia–reperfusion injury through upregulating metabolite 6-ketoLCA. Hepatology Communications 2026; 10(5) doi: 10.1097/HC9.0000000000000916
|
| 21 |
Hung Thai Vu, Vien Duc Nguyen, Hiroko Ikenaga, Tsutomu Matsubara. Application of PPAR Ligands and Nanoparticle Technology in Metabolic Steatohepatitis Treatment. Biomedicines 2024; 12(8) doi: 10.3390/biomedicines12081876
|
| 22 |
Pei‐Xuan Ji, Yu‐Xin Chen, Xi‐Xi Ni, Qi Miao, Jing Hua. Effect of triggering receptor expressed on myeloid cells 2‐associated alterations on lipid metabolism in macrophages in the development of non‐alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 2024; 39(2) doi: 10.1111/jgh.16417
|
| 23 |
A. N. Abd Halim, N. A. S. Zikri, Z. Ngaini, N. H. Zamakshshari, Y. K. Wei, D. Noissy Diosing. Synthesis In Silico and ADMET Profile of Triazinethione Derivatives for Their Potential as Anti-Inflammatory Agents. Russian Journal of General Chemistry 2023; 93(11) doi: 10.1134/S1070363223110208
|
| 24 |
Kaipeng Hu, Siyuan Liu, Shuyan Sheng, Shaobo Zhang, Binghua Li, Beicheng Sun, Anliang Xia. Heterogeneity of hepatic macrophages in MASLD/MASH: Lipid-associated programs, molecular mechanisms, spatial niches, and therapeutic implications. iLIVER 2026; 5(2) doi: 10.1016/j.iliver.2026.100234
|
| 25 |
Mengjing Zhao, Min Zhang, Shoudong Ni. Role of ginsenoside Rg1 as a PPAR-γ activator in protecting against manganese-induced hepatotoxicity: Insights into the TLR4/MyD88/MAPK signaling pathway. Ecotoxicology and Environmental Safety 2025; 290 doi: 10.1016/j.ecoenv.2024.117573
|